Parafollicular Cells, also known as C cells, are specialized endocrine cells located within the thyroid gland, specifically in the connective tissue between thyroid follicles. These cells play a crucial role in regulating calcium homeostasis and are distinct from the follicular cells that produce thyroid hormones. The primary function of parafollicular cells is to secrete calcitonin, a hormone that participates in the control of blood calcium levels. Calcitonin acts by inhibiting the activity of osteoclasts, cells responsible for breaking down bone tissue and releasing calcium into the bloodstream. As a result, calcitonin helps to reduce blood calcium levels, opposing the effects of parathyroid hormone (PTH). Parafollicular cells originate from neural crest cells during embryonic development and migrate to the thyroid gland. Their presence is most prominent in the upper and lower poles of the thyroid lobes. Immunohistochemical staining techniques, such as using antibodies against calcitonin, enable the identification of parafollicular cells in histological sections. Dysfunction or abnormalities in parafollicular cells can lead to imbalances in calcium regulation and contribute to conditions like medullary thyroid carcinoma (MTC). MTC is a rare type of thyroid cancer that arises from parafollicular cells and may be associated with genetic mutations. Calcitonin assays are employed clinically to assess parafollicular cell activity and aid in the diagnosis of MTC. Elevated levels of calcitonin in the blood may indicate the presence of MTC, prompting further investigation and management. Research on parafollicular cells continues to advance our understanding of their physiological roles and their implications in health and disease. Unraveling the intricate mechanisms of calcitonin secretion and the regulation of parafollicular cell function holds promise for developing targeted therapies for disorders related to calcium metabolism and thyroid cancer.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy